NCT00006493View on ClinicalTrials.gov

Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV InfectionsHyperlipidemia

Interventions

DRUG

Rosiglitazone

Trial Locations (1)

10016

Division of Endocrinology, New York

All Listed Sponsors

lead

National Center for Research Resources (NCRR)

NIH

NCT00006493 - Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia | Biotech Hunter | Biotech Hunter